SANTOS LTD/ AU000000STO6 /
5/24/2024 8:01:42 AM | Chg. +0.0200 | Volume | Bid9:58:47 PM | Ask9:58:47 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.5830EUR | +0.44% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 15.23 bill.EUR | - | - |
GlobeNewswire
5/24
The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth
GlobeNewswire
5/21
FII Institute Unveils Top Speakers, Sessions for Inaugural Latin America Summit in June
GlobeNewswire
5/17
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and ...
GlobeNewswire
5/16
Bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protec...
GlobeNewswire
5/14
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
5/7
Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S.
GlobeNewswire
5/7
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Upd...
GlobeNewswire
4/24
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progres...
GlobeNewswire
4/24
Dickey’s Barbecue in the Lineup for Dallas Cowboys Draft Party presented by Miller Lite
GlobeNewswire
4/24
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire
4/23
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology...
GlobeNewswire
4/23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
Newsfile Corp
4/18
Creative Heart Awakenings' Founder Announces the Launch Event of Her Book "HeART Healing for Radiant...